IMMUNE RESPONSE ENHANCING GLUCAN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12212352

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention discloses a composition for enhancing the protective immunity in a subject, comprising an effective amount of a β-glucan and a vaccine, wherein the β-glucan enhances the immune response of the vaccine against cancer or infectious agents. The infectious agents can be viruses, fungi, bacteria or parasites. In one embodiment, the β-glucan is derived from yeast and comprises side chains attached to a β-(1,3) backbone. In another embodiment, the vaccine comprises an antibody and whole tumor cells. The invention also provides a method of enhancing protective immunity using said composition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH1275 YORK AVENUE NEW YORK NY 10021
BIOTEC PHARMACON ASA9008 TROMSÖ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHEUNG, Nai-Kong V Purchase, US 71 533
Engstad, Rolf Einar Tromoso, NO 5 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation